Inhibitory effect of tranilast on prostaglandin D synthetase.

The effect of Tranilast [N-(3,4-dimethoxycinnamoyl) anthranilic acid] on the synthesis of prostaglandin D2 (PGD2) by homogenates of rat peritoneal mast cells was investigated. The major cyclooxygenase product formed by mast cell homogenates was PGD2, smaller quantities of PGE2 and PGF2 alpha were also formed. Tranilast suppressed the production of PGD2 in a dose-dependent manner with an IC50 of 0.1 mM. This suppression was due to inhibition of PGD synthetase, but not cyclooxygenase, since the formation of PGE2 and PGF2 alpha were unchanged at a 0.1 mM concentration. In addition, the glutathione-dependent conversion of [14C]PGH2 to PGD2 by PGD synthetase (PGH-D isomerase, EC 5.3.99.2) was inhibited by Tranilast, with 50% inhibition achieved at 0.08 mM in broken cell preparations of rat peritoneal mast cells. Tranilast also inhibited purified rat spleen and brain PGD synthetases. Furthermore, Tranilast prevented the PGD2 generation from intact mast cells stimulated by the calcium ionophore A23187. These results suggest that Tranilast exerts some of its therapeutic effects by prevention of PGD2 generation in mast cells and some other tissues.

[1]  Y. Urade,et al.  Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. , 1988, Archives of biochemistry and biophysics.

[2]  D. Kennerly,et al.  Activation of phospholipid metabolism during mediator release from stimulated rat mast cells. , 1979, Journal of immunology.

[3]  T. Ruzicka,et al.  Inhibition of rat mast cell arachidonic acid cyclooxygenase by dapsone. , 1983, The Journal of allergy and clinical immunology.

[4]  K. Ikai,et al.  Prostaglandin D2 in the Skin , 1988, International journal of dermatology.

[5]  S. Holgate,et al.  Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. , 1984, Journal of immunology.

[6]  J. Oates,et al.  Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. , 1982, Journal of immunology.

[7]  J. Oates,et al.  Increased production of prostaglandin D2 in patients with systemic mastocytosis. , 1980, The New England journal of medicine.

[8]  H. Azuma,et al.  PHARMACOLOGICAL PROPERTIES OF N‐(3′,4′‐DIMETHOXYCINNAMOYL) ANTHRANILIC ACID (N‐5′), A NEW ANTI‐ATOPIC AGENT , 1976, British journal of pharmacology.

[9]  S. Peters,et al.  Effect of prostaglandin D2 in modulating histamine release from human basophils. , 1984, The Journal of pharmacology and experimental therapeutics.

[10]  M. Kaliner,et al.  The effects of histamine and prostaglandin D2 on rat mast-cell cyclic AMP and mediator release. , 1981, The Journal of allergy and clinical immunology.

[11]  Y. Urade,et al.  Characterization and distribution of prostaglandin D synthetase in rat skin. , 1988, The Journal of investigative dermatology.

[12]  Y. Urade,et al.  Biochemical and immunological characterization of rat spleen prostaglandin D synthetase. , 1987, The Journal of biological chemistry.

[13]  K. Danno,et al.  Effect of 8-methoxypsoralen plus long-wave ultraviolet (PUVA) radiation on mast cells. II. In vitro PUVA inhibits degranulation of rat peritoneal mast cells induced by compound 48/80. , 1986, The Journal of investigative dermatology.

[14]  Y. Yanagihara,et al.  Inhibition of hypersensitivity reactions by a new drug, N(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'). , 1976, The Journal of allergy and clinical immunology.

[15]  Y. Urade,et al.  Purification and characterization of rat brain prostaglandin D synthetase. , 1985, The Journal of biological chemistry.

[16]  A. Mallet,et al.  Prostaglandin D2 release by guinea pig skin during in vitro anaphylaxis induced by antigen and compound 48/80. , 1987, The Journal of investigative dermatology.

[17]  S. Yamamoto,et al.  Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. , 1979, The Journal of biological chemistry.

[18]  Robert A. Lewis,et al.  Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds , 1981, Nature.

[19]  S. Peters,et al.  Arachidonic acid metabolism in purified human lung mast cells. , 1984, Journal of immunology.